Hypertension, Vol 6, 568-573, Copyright © 1984 by American Heart Association
LA Kamal, KH Le Quan-Bui and P Meyer
The uptake and content of serotonin in blood platelets were studied in
patients with essential hypertension and in five families in which at least
one member was hypertensive. Blood was obtained from male and female
normotensive volunteers and hypertensive patients who were free of
medication. Lineweaver-Burk plots of 3H-serotonin uptake from both control
subjects and hypertensive patients were linear, which suggested simple
Michaelis-Menten uptake kinetics. The maximal uptake velocity (Vmax) in
hypertensive patients was significantly lower than in control subjects
(control = 41.7 +/- 3.3 pmol/min/10(8) platelets, n = 17; hypertensive =
26.6 +/- 3.0 pmol/min/10(8) platelets, n = 16; p less than 0.005). The
affinity constant (Km) was slightly but significantly lower in hypertensive
patients (control = 0.70 +/- 0.08 microM; hypertensive = 0.46 +/- 0.08
microM; p less than 0.05). The serotonin content in blood platelets
determined by high pressure liquid chromatography with electrochemical
detection was significantly lower in hypertensive patients (control = 165.0
+/- 12.9 nmol/10(11) platelets, n = 29; hypertensive = 105.9 +/- 10.4
nmol/10(11) platelets, n = 27; p less than 0.001). In the five families
investigated, the lowered serotonin content was observed in some
normotensive members. The reduced number of carriers of serotonin uptake
and the slight decrease in the affinity constant observed in platelets of
patients with essential hypertension suggest that serotonin metabolism is
altered in essential hypertension and that blood platelets may be a useful
model in studying the serotonergic modifications at the molecular level.
ARTICLES
Decreased uptake of 3H-serotonin and endogenous content of serotonin in blood platelets in hypertensive patients
This article has been cited by other articles:
![]() |
D. L. Musselman, U. M. Marzec, A. Manatunga, S. Penna, A. Reemsnyder, B. T. Knight, A. Baron, S. R. Hanson, and C. B. Nemeroff Platelet Reactivity in Depressed Patients Treated With Paroxetine: Preliminary Findings Arch Gen Psychiatry, September 1, 2000; 57(9): 875 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Watts and G. D. Fink 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H944 - H952. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |